Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 3,631 shares at $18.04 ($66K) on 2026-02-25, disclosed to the SEC on 2026-02-27.
Scheduled sale ($66k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.04 | 523 | $9K | 14.4% |
| 2 | $18.04 | 3,108 | $56K | 85.6% |
| Total | $18.04 avg | 3,631 | $66K | 100% |
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |